These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 30975533)

  • 1. Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
    Jeon SK; Lee JM; Joo I; Yoon JH; Lee DH; Lee JY; Han JK
    Ultrasound Med Biol; 2019 Jun; 45(6):1407-1416. PubMed ID: 30975533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A Pilot Study Using MRI-Derived Proton Density Fat Fraction as the Gold Standard.
    Ferraioli G; Maiocchi L; Raciti MV; Tinelli C; De Silvestri A; Nichetti M; De Cata P; Rondanelli M; Chiovato L; Calliada F; Filice C
    Clin Transl Gastroenterol; 2019 Oct; 10(10):e00081. PubMed ID: 31609745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Attenuation Coefficient Measurement Using an Ultrasound-Guided Attenuation Parameter for Evaluation of Hepatic Steatosis: Comparison With MRI-Determined Proton Density Fat Fraction.
    Tada T; Kumada T; Toyoda H; Kobayashi N; Sone Y; Oguri T; Kamiyama N
    AJR Am J Roentgenol; 2019 Feb; 212(2):332-341. PubMed ID: 30476453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
    Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
    Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-Derived Fat Fraction for Hepatic Steatosis Assessment: Prospective Study of Agreement With MRI PDFF and Sources of Variability in a Heterogeneous Population.
    Kubale R; Schneider G; Lessenich CPN; Buecker A; Wassenberg S; Torres G; Gurung A; Hall T; Labyed Y
    AJR Am J Roentgenol; 2024 Jun; 222(6):e2330775. PubMed ID: 38506537
    [No Abstract]   [Full Text] [Related]  

  • 6. iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study.
    Hirooka M; Ogawa S; Koizumi Y; Yoshida Y; Goto T; Yasuda S; Yamahira M; Tamai T; Kuromatsu R; Matsuzaki T; Suehiro T; Kamada Y; Sumida Y; Hiasa Y; Toyoda H; Kumada T
    J Gastroenterol; 2024 Jun; 59(6):504-514. PubMed ID: 38553657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
    Jeon SK; Lee JM; Joo I; Park SJ
    Korean J Radiol; 2021 Jul; 22(7):1077-1086. PubMed ID: 33739636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes.
    Dioguardi Burgio M; Castera L; Oufighou M; Rautou PE; Paradis V; Bedossa P; Sartoris R; Ronot M; Bodard S; Garteiser P; Van Beers B; Valla D; Vilgrain V; Correas JM;
    Clin Gastroenterol Hepatol; 2024 May; 22(5):1005-1013.e27. PubMed ID: 38072287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.
    Tran BV; Ujita K; Taketomi-Takahashi A; Hirasawa H; Suto T; Tsushima Y
    PLoS One; 2021; 16(8):e0255768. PubMed ID: 34383812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the Attenuation Imaging Technology in the Detection of Liver Steatosis.
    Ferraioli G; Maiocchi L; Savietto G; Tinelli C; Nichetti M; Rondanelli M; Calliada F; Preda L; Filice C
    J Ultrasound Med; 2021 Jul; 40(7):1325-1332. PubMed ID: 32960457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation imaging based on ultrasound technology for assessment of hepatic steatosis: A comparison with magnetic resonance imaging-determined proton density fat fraction.
    Tada T; Kumada T; Toyoda H; Nakamura S; Shibata Y; Yasuda S; Watanuki Y; Tsujii K; Fukuda N; Fujioka M; Takeshima K; Niwa F; Ogawa S; Hashinokuchi S; Kataoka S; Ichikawa H; Iijima H
    Hepatol Res; 2020 Dec; 50(12):1319-1327. PubMed ID: 32876367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of Hepatic Steatosis by Ultrasound: Prospective Comparison With MRI Proton Density Fat Fraction as Reference Standard.
    Dillman JR; Thapaliya S; Tkach JA; Trout AT
    AJR Am J Roentgenol; 2022 Nov; 219(5):784-791. PubMed ID: 35674351
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
    Han A; Zhang YN; Boehringer AS; Montes V; Andre MP; Erdman JW; Loomba R; Valasek MA; Sirlin CB; O'Brien WD
    Radiology; 2020 Apr; 295(1):106-113. PubMed ID: 32013792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis With Reference to MRI-PDFF in a Large Cohort.
    Imajo K; Toyoda H; Yasuda S; Suzuki Y; Sugimoto K; Kuroda H; Akita T; Tanaka J; Yasui Y; Tamaki N; Kurosaki M; Izumi N; Nakajima A; Kumada T
    Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2533-2541.e7. PubMed ID: 34768008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of Attenuation to Stage Liver Steatosis with MRI Proton Density Fat Fraction as Reference: A Prospective Comparison of Three US Machines.
    Cassinotto C; Jacq T; Anselme S; Ursic-Bedoya J; Blanc P; Faure S; Belgour A; Guiu B
    Radiology; 2022 Nov; 305(2):353-361. PubMed ID: 35819322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique.
    Bae JS; Lee DH; Lee JY; Kim H; Yu SJ; Lee JH; Cho EJ; Lee YB; Han JK; Choi BI
    Eur Radiol; 2019 Dec; 29(12):6499-6507. PubMed ID: 31175413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference.
    Wang JH; Ou HY; Yen YH; Chen CH; Lu SN
    Dig Dis Sci; 2020 May; 65(5):1512-1519. PubMed ID: 31617130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of US attenuation imaging for the detection and severity grading of hepatic steatosis in routine abdominal ultrasonography.
    Kwon EY; Kim YR; Kang DM; Yoon KH; Lee YH
    Clin Imaging; 2021 Aug; 76():53-59. PubMed ID: 33549920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Ultrasound Shear Wave Elastography Techniques as Novel Imaging-Based Approaches for Quantitative Evaluation of Hepatic Steatosis-Preliminary Findings.
    Platz Batista da Silva N; Scharf G; Lürken L; Verloh N; Schleder S; Stroszczynski C; Jung EM; Haimerl M
    Tomography; 2023 Mar; 9(2):681-692. PubMed ID: 36961013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutoff Values for Diagnosing Hepatic Steatosis Using Contemporary MRI-Proton Density Fat Fraction Measuring Methods.
    Park S; Kwon JH; Kim SY; Kang JH; Chung JI; Jang JK; Jang HY; Shim JH; Lee SS; Kim KW; Song GW
    Korean J Radiol; 2022 Dec; 23(12):1260-1268. PubMed ID: 36447414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.